The information provided here is meant to give you a general idea about each of the medications listed below. Only the most general side effects are included, so ask your healthcare provider if you need to take any special precautions. Use each of these medications as recommended by your healthcare provider, or according to the instructions provided. If you have further questions about usage or side effects, contact your healthcare provider.
GnRH agonists block the release of hormones that cause ovulation. As a result, estrogen is not produced. This stops the menstrual cycle and helps to relieve the symptoms of endometriosis.
For women with endometriosis, GnRH agonists can have the following health benefits:
A GnRH agonist can be given by injection or through a nasal spray. It is usually prescribed for 6 months or more. Side effects are common and can vary depending on the drug taken. They can be severe in some women.
Possible side effects include:
GnRH agonists have been shown to decrease bone density. Talk to your doctor about this risk; it may affect how long you can take these drugs. You may need to take a calcium supplement.
GnRH agonists are known to cause birth defects. Do not take this medication if there is a chance that you can become pregnant.
Danazol is a synthetic androgen, which is a male hormone. Danazol helps relieve the symptoms of endometriosis by stopping reproductive hormones from being made and by stopping the menstrual cycle.
Danazol can have the following benefits:
Danazol is taken in pill form, typically three times per day for 6-9 months at a time. It is sometimes given with oral contraceptives to decrease possible side effects. Most of the side effects are due to the effects of the male hormone. Most are relatively mild and stop when treatment stops.
Possible side effects include:
Danazol is known to cause birth defects. Do not take this medication if there is a chance that you can become pregnant.
Progestin is one of the hormones that are naturally released by the ovary during the menstrual cycle. Taken as medication, it stops ovulation and the menstrual cycle. Progestins can be very effective for controlling the mild-to-moderate symptoms of endometriosis. They can be given as long-term therapy and can be especially useful in women who do not want to become pregnant.
Progestins can have the following health benefits:
Progestins are taken in pill form, by injection, or by delivery from an intrauterine device. Injections are typically given once every 3 months. Progestin in pill form can be given as progestin alone or as an estrogen/progestin-combined oral contraceptive. In pill form, it is taken once per day and should be taken at approximately the same time every day. If it causes nausea, it should be taken just before bedtime.
Possible side effects include:
In premenopausal women, such as women with endometriosis, aromatase inhibitor regimens require concomitant ovarian suppression with a GnRH agonist, progestin, or combined oral contraceptive. The most attractive combination is probably the oral contraceptive plus aromatase inhibitor. The side effects are comparable to other treatments, but do not include the risk of bone density loss experienced with GnRH agonist.
Common names include:
NSAIDs are pain relievers. If pain is expected (for example, during your menstrual period), these medications work best when taken on a scheduled rather than an as-needed basis. The dose depends on the amount of pain. For severe pain, NSAIDs are available in higher doses by prescription. These medications should be taken with food and a full glass of water.
NSAIDs are known to increase bleeding. If you are going to have surgery or a biopsy, tell your healthcare provider that you are taking these medications. Also, they should be used with caution if you have a stomach ulcer, high blood pressure, kidney disease, or are taking blood thinners.
If you are taking medications, follow these general guidelines:
Abou-Setta AM, Al-Inany HG, et al. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database of Systematic Reviews. 2006;(4):CD005072.
Allen C, Hopewell S, et al. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews. 2005;(4):CD004753.
Appleyard TL, Mann CH, et al. Guidelines for the management of pelvic pain associated with endometriosis: a systematic appraisal of their quality. BJOG. 2006;113(7):749-757.
Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril. 2006;85:1307-1318.
Endometriosis. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/resultlist/dmp~AN~T900174/Epilepsy-in-children?q=endometriosis&filter=all. Updated May 25, 2017. Accessed September 12, 2017.
Farquhar C, Sutton C. The evidence for the management of endometriosis. Curr Opinion in Obstet & Gynecol. 1998;10(4):321-332.
Medical Management of Endometriosis. The American College of Obstetricians and Gynecologists, Practice Bulletin No. 11. Dec 1999.
Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2000;(2):CD001019.
Razzi S, Fava A, et al. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. BJOG. 2004;111:182-184.
Selak V, Farquhar C, et al. Danazol for pelvic pain associated with endometriosis [update]. Cochrane Database of Systematic Reviews. 2001;(4):CD000068.
Shippen E, West WJ. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril. 2004;81:1395-1398.
Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet & Gynecol. 2002;99(5):709-719.
Vercellini P, Cortesi I, et al. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertility & Sterility. 1997;68(3):393-401.
Yap C, Furness S, et al. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews. 2004;(3):CD003678.
3/12/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T115220/Endometriosis: Seracchioli R, Mabrouk M, Frascà C, et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril. 2010;93(1):52-56.
Last reviewed September 2017 by EBSCO Medical Review Board Beverly Siegal, MD, FACOG
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2012 EBSCO Publishing All rights reserved.
What can we help you find?close ×